Company intelligence / Profile preview

VCBeat

Beijing, Beijing, China

Ownership: Private
Employees: ~150
Development stage: Other

Overview

VCBeat, also known as Artery Network (Dongmai Wang), is a leading Chinese healthcare industrial service platform focusing on digital health, medical devices, biotechnology, and pharmaceutical innovation. The company provides a comprehensive suite of services including industry news, deep-dive research reports, financial data through its VBData platform, and professional consulting. VCBeat is well-known for hosting major industry events such as the Future Healthcare VB100 Conference and publishing the 'Future Healthcare 100' rankings. It serves as a critical bridge between healthcare startups, established corporations, and investors within the Chinese and global healthcare ecosystems.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on VCBeat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VCBeat.

Explore the full profile